Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2019 20:54 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Completes Deferral Transaction with Former Shareholders of Talent Biotechs

SAN FRANCISCO, and TEL AVIV, Israel, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today completed certain...
January 31, 2019 14:23 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Change to Scope of Services under Payments Agreements with Salzman Group and Next Share Issuance

SAN FRANCISCO and TEL AVIV, Israel, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
January 28, 2019 13:35 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Grant of Stock Options to Certain Directors and Employees

SAN FRANCISCO and TEL AVIV, ISRAEL , Jan. 28, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
January 22, 2019 17:58 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANCISCO...
January 15, 2019 20:19 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants

SAN FRANCISCO and TEL AVIV, Israel, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this...
January 14, 2019 15:34 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Share Issuance and Extension to March 1 under Payments Agreements with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
January 11, 2019 11:13 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants

/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company” or...
December 18, 2018 21:26 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES SAN FRANCISCO and TEL AVIV, Israel, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company” or...
December 04, 2018 13:02 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Additional Share Issuance for Services under Payments Agreement with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
November 30, 2018 07:30 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Reports Third Quarter 2018 Financial Results

SAN FRANCISCO and TEL AVIV, Israel, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today reported financial results...